Lung Cancer Screening in Singapore: Who Needs a Low-Dose CT

Lung cancer remains the leading cause of cancer death among men in Singapore, and one of the leading causes among women. The reason it kills so effectively is not that it is untreatable. It is that it is almost always found late. A tumour can grow in the lung for years without producing a symptom, because lung tissue itself has no pain receptors and there is enough spare capacity that breathing feels normal until a great deal has been lost.

By the time a persistent cough, breathlessness, chest pain or coughing up blood brings someone to a doctor, the disease is frequently advanced and five-year survival is poor. Found at stage one, the picture is entirely different, with the majority of patients surviving five years or more. That gap between late and early detection is what screening exists to close.

What low-dose CT screening is

Low-dose computed tomography, usually written LDCT, is a chest CT performed with a radiation dose several times lower than a standard diagnostic CT, comparable in magnitude to a few months of natural background exposure. It takes seconds, requires no contrast injection and no fasting, and involves lying still on a table and holding your breath once.

What it produces is a set of cross-sectional images detailed enough to identify nodules only a few millimetres across, which is far beyond what a chest X-ray can detect. This distinction matters, because it is the reason chest X-ray is not recommended as a screening test. Trials of X-ray screening failed to reduce lung cancer mortality. Trials of LDCT succeeded.

The two landmark studies are the National Lung Screening Trial in the United States, which reported a twenty percent reduction in lung cancer mortality in high-risk smokers screened with LDCT compared with X-ray, and the NELSON trial in Europe, which reported a similar or greater reduction against no screening. These results are the basis for LDCT screening recommendations worldwide.

Who should be screened in Singapore

Singapore's clinical guidance, in line with international consensus, focuses screening on people at substantially elevated risk rather than the general population. The core criteria are age and smoking history.

Screening is generally considered appropriate for adults from around the age of fifty to fifty-five up to about seventy-five, who have a smoking history of at least twenty pack-years, and who either still smoke or quit within the last fifteen years.

A pack-year is one pack of twenty cigarettes a day for one year. Twenty a day for twenty years is twenty pack-years. Forty a day for ten years is also twenty pack-years. It is worth doing the arithmetic honestly, because many people underestimate their own history considerably.

The never-smoker question in Asia

There is an important regional caveat that the Western criteria do not capture well. A substantially higher proportion of lung cancers in East and Southeast Asia occur in people who have never smoked than in Europe or North America, and this pattern is particularly marked in women. Adenocarcinoma driven by EGFR mutations is the dominant subtype in this group.

The reasons are not fully established, and likely include genetic susceptibility, long-term second-hand smoke exposure, cooking fume exposure, occupational exposures and ambient air pollution, including the transboundary haze episodes that periodically affect the region.

This does not mean every never-smoker should have a CT scan. Screening a low-risk population produces a poor ratio of benefit to harm, because the great majority of findings will be benign and each one generates anxiety, follow-up imaging and occasionally an invasive procedure. What it does mean is that risk assessment in Singapore should not stop at the pack-year count. A never-smoker with a first-degree relative who had lung cancer, significant occupational exposure to asbestos, silica or diesel exhaust, prolonged second-hand smoke exposure, or a history of chronic lung disease may warrant a discussion that the standard criteria would not trigger.

Eligibility criteria for low-dose CT, summarised

Putting the criteria together in one place makes them easier to check against your own history. A person is generally considered eligible for low-dose CT lung screening when all of the following apply:

• Age roughly between fifty and seventy-five years old.
• Smoking history of at least twenty pack-years, calculated as packs per day multiplied by years smoked.
• Current smoking status, or having quit within the last fifteen years. Someone who quit twenty years ago and has otherwise remained healthy generally falls outside the standard criteria, since risk declines substantially with time since cessation.
• Fitness for treatment. Screening is intended for people who would be able to undergo further investigation and, if needed, treatment such as surgery. It is not generally recommended for someone with a health condition severe enough that a cancer diagnosis would not change management.

Outside the standard criteria, an individualised discussion is reasonable for people with a first-degree relative diagnosed with lung cancer, documented occupational exposure to asbestos, silica, diesel exhaust or radon, chronic obstructive pulmonary disease or pulmonary fibrosis, or prolonged domestic exposure to second-hand smoke or unventilated cooking fumes. None of these factors alone triggers automatic screening under current criteria, but they shift the balance of the conversation with a doctor, particularly in a population where a meaningful share of lung cancers occur outside the classic smoker profile.

Someone who meets the criteria on age and smoking history but has a competing health condition likely to limit life expectancy to a few years regardless of lung cancer status is generally a poor candidate, since the benefit of early detection depends on having enough remaining life expectancy for it to matter, and the harms of a false alarm remain the same regardless.

What the scan can find, and what happens next

Nodules are common and usually benign

The single most important thing to understand before being screened is that finding a nodule is normal. A large proportion of people screened will have at least one small pulmonary nodule, and the overwhelming majority are entirely benign: old scarring from a previous infection, a healed granuloma from tuberculosis exposure, or a small lymph node. Given the historical prevalence of tuberculosis in this region, benign granulomas are especially common on scans here.

Nodules are assessed by size, density, shape and growth over time. Radiologists commonly use the Lung-RADS system, which sorts findings into categories with a defined management pathway attached to each. Small, smooth, dense nodules are usually watched with a repeat scan at an interval. Larger nodules, those with irregular or spiculated margins, or those that grow between scans, prompt further investigation with PET-CT or biopsy.

The harms worth understanding

Screening is not free of downside, and any clinic that presents it as such is not giving you the full picture.

False positives. A finding that requires follow-up but turns out to be benign is the most common adverse outcome. It generates worry and additional imaging. Structured reporting systems have substantially reduced unnecessary invasive procedures, but they have not eliminated the anxiety.

Radiation. Low-dose CT uses a small fraction of a standard CT dose, but repeated annual scanning does accumulate. In a genuinely high-risk person the mortality benefit clearly outweighs this. In a low-risk person it may not.

Overdiagnosis. Some detected cancers would never have progressed to cause symptoms or death within the person's lifetime. Treating those cancers causes harm with no benefit. This is difficult to quantify at an individual level and is a real, if modest, cost of screening.

Incidental findings. A chest CT visualises the heart, great vessels, thyroid, oesophagus, liver and adrenals. Coronary calcification is frequently visible and is genuinely useful cardiovascular information. Other incidental findings may require investigation of their own.

Living with a false positive or an incidental finding

A finding flagged for follow-up is, statistically, far more likely to be nothing than something, and it is worth internalising that before the follow-up scan rather than after. Most programmes report that only a small minority of flagged nodules turn out to be malignant, and the structured Lung-RADS reporting system exists specifically to reduce the number of people sent for biopsy on the basis of a finding that a repeat scan at three or six months would have shown was stable and benign.

The practical advice for the waiting period between an initial flag and a follow-up scan is straightforward: keep the follow-up appointment, because it is the resolution to the uncertainty, and avoid searching online for nodule size and cancer probability calculators, which are frequently misapplied outside the specific context they were validated in and tend to generate disproportionate anxiety.

Incidental findings outside the lungs deserve a measured response too. Coronary artery calcification seen incidentally on a lung screening scan is a genuinely useful early warning of cardiovascular risk and is worth discussing with a doctor even though it was not what the scan was ordered to find. A small adrenal nodule, thyroid nodule or liver lesion picked up incidentally is common in the general population and usually benign, but it does need documented follow-up according to established radiology protocols, both so it is not forgotten and so it is not chased unnecessarily. A doctor who orders the scan should be the same person who talks you through the report line by line, rather than leaving you to interpret radiology terminology alone.

What screening does not replace

Nothing in a screening programme comes close to the benefit of not smoking. Smoking cessation reduces lung cancer mortality by considerably more than LDCT screening does, and the two are complementary rather than alternatives. A screening appointment that does not include a serious conversation about quitting has missed the larger intervention.

The recovery timeline after quitting is meaningful even for long-term smokers: lung cancer death rate falls to around half that of a continuing smoker by ten years after cessation. We cover the full timeline in our guide to quitting smoking.

Symptoms that need assessment regardless of screening

Screening is for people without symptoms. If any of the following are present, the correct pathway is diagnostic assessment now, not a screening appointment at some future date:

• A cough persisting beyond three weeks, or a change in the character of a long-standing cough
• Coughing up blood, in any quantity
• Unexplained breathlessness or new wheeze
• Chest, shoulder or back pain that persists
• Unintentional weight loss
• Hoarseness lasting more than three weeks
• Recurrent chest infections
• Persistent fatigue with any of the above

How screening fits into a broader assessment

In practice, most people considering lung screening are also in the group that should be thinking about cardiovascular risk, since smoking and age drive both. A sensible approach pairs an LDCT decision with blood pressure, a lipid panel including advanced markers, glucose handling and a discussion of other age-appropriate cancer screening such as colorectal.

The scan itself is the easy part. The value lies in deciding correctly whether you should have one, and in having someone competent explain what a five-millimetre nodule on the right upper lobe actually means before you spend three months assuming the worst.

Related reading: health screening in Singapore, quitting smoking, before and after, and the big three: blood pressure, cholesterol and diabetes.

Frequently Asked Questions

Q: Who qualifies for lung cancer screening in Singapore?

A: The core group is adults roughly between fifty and seventy-five with a smoking history of at least twenty pack-years, who currently smoke or quit within the past fifteen years. Beyond that, risk assessment should consider family history of lung cancer, occupational exposures such as asbestos or silica, prolonged second-hand smoke exposure and chronic lung disease, all of which may justify a discussion even outside the standard criteria.

Q: Is a chest X-ray good enough instead of a CT scan?

A: No. Chest X-ray has been tested as a screening tool in large trials and did not reduce lung cancer deaths, because it cannot reliably detect small early tumours. Low-dose CT can identify nodules of a few millimetres and is the only imaging test shown to reduce lung cancer mortality. A normal chest X-ray does not exclude early lung cancer.

Q: How much radiation is involved in a low-dose CT?

A: Considerably less than a standard diagnostic chest CT, at a level broadly comparable to a few months of natural background radiation. For someone at genuinely high risk, the mortality benefit outweighs this comfortably. For someone at low risk undergoing repeated annual scans, the calculation is less favourable, which is one reason screening is targeted rather than universal.

Q: They found a nodule. Does that mean I have cancer?

A: Almost certainly not. Small pulmonary nodules are extremely common and the overwhelming majority are benign, often old scarring from previous infection, which is particularly common in this region given historical tuberculosis exposure. Nodules are graded by size, shape and density, and most are managed with a repeat scan at a defined interval rather than any intervention.

Q: I have never smoked. Should I be screened?

A: Routine screening is not recommended for never-smokers, because the low underlying risk means most findings would be false positives. That said, a higher share of lung cancers in Asian populations occurs in never-smokers than in Western populations, so if you have a family history, significant second-hand smoke or occupational exposure, or chronic lung disease, an individual risk discussion with a doctor is reasonable.

Q: How often should screening be repeated?

A: Annually while you continue to meet the risk criteria, is the standard approach, with the interval adjusted if a nodule requires shorter-interval follow-up. Screening is generally stopped once someone has been free of smoking for more than fifteen years, exceeds the upper age range, or develops a health condition that would preclude treatment were a cancer found.

Book a health screening at our Orchard clinic or speak to a doctor about whether lung screening is appropriate for you.